"ID_Trait";"Trait_Name";"Subtraits";"Parent_Trait";"Notes"
"2";"-----------";"Migration & Invasion";"0";
"3";"-----------";;"0";
"4";"Acute Lymphoblastic Leukemia (ALL)";"ALL with KMT2A-AFF1 gene fusion";"0";
"5";"Acute Lymphoblastic Leukemia (ALL)";"T-ALL";"0";
"6";"Acute Lymphoblastic Leukemia (ALL)";"-";"0";
"7";"Acute Lymphoblastic Leukemia (ALL)";"BCP-ALL";"0";
"8";"Acute Lymphoblastic Leukemia (ALL)";"BCP-ALL with high IL-23 expression";"0";
"9";"Acute Lymphoblastic Leukemia (ALL)";"T-ALL with high ST6GALI expression";"0";
"10";"Acute Lymphoblastic Leukemia (ALL)";"MLL-AF4-positive ALL cells";"0";
"11";"Acute Lymphoblastic Leukemia (ALL)";"TAL1-negative T-ALL";"0";
"12";"Acute Lymphoblastic Leukemia (ALL)";"TAL1-positive T-ALL";"0";
"13";"Acute Lymphoblastic Leukemia (ALL)";"Imatinib-resistant cells";"0";
"14";"Acute Lymphoblastic Leukemia (ALL)";"B-ALL";"0";
"15";"Acute Lymphoblastic Leukemia (ALL)";"ALL with TEL-AML1 fusion gene";"0";
"16";"Acute Lymphoblastic Leukemia (ALL)";"Etoposide-resistant T-ALL";"0";
"17";"Acute Lymphoblastic Leukemia (ALL)";"t(4;11)-positive infant ALL";"0";
"18";"Acute Lymphoblastic Leukemia (ALL)";"TLX3-positive HPB-ALL";"0";
"19";"Acute Lymphoblastic Leukemia (ALL)";"TCF3-rearranged BCP-ALL";"0";
"20";"Acute Lymphoblastic Leukemia (ALL)";"T leukemia homeobox 3 (TLX3)�knocked down";"0";
"21";"Acute Lymphoblastic Leukemia (ALL)";"Glucocorticoid (GC)-resistant ALL";"0";
"22";"Acute Lymphoblastic Leukemia (ALL)";"MLL�AF4 fusion gene postive";"0";
"23";"Acute Lymphoblastic Leukemia (ALL)";"MLL�ENL fusion gene positive";"0";
"24";"Acute Lymphoblastic Leukemia (ALL)";"BCP-ALL [ETV6/RUNX1-positive]";"0";
"25";"Acute Myeloid Leukemia (AML)";"-";"0";
"26";"Acute Myeloid Leukemia (AML)";"AML with FLT3-ITD positive";"0";
"27";"Acute Myeloid Leukemia (AML)";"AML with FLT3-wt overexpression";"0";
"28";"Acute Myeloid Leukemia (AML)";"FLT3-ITD positive";"0";
"29";"Acute Myeloid Leukemia (AML)";"MLL�AF4 fusion gene positive";"0";
"30";"Acute Myeloid Leukemia (AML)";"MLL-rearrangement";"0";
"31";"Acute Myeloid Leukemia (AML)";"MLL-rearrengement";"0";
"32";"Acute Myeloid Leukemia (AML)";"AML with t(8;21)";"0";
"33";"Acute Myeloid Leukemia (AML)";"FLT3-ITD-positive";"0";
"34";"Acute Myeloid Leukemia (AML)";"MLL-rearrangement (MLL-AF9)";"0";
"35";"Acute Myeloid Leukemia (AML)";"t(8;21) positive";"0";
"36";"Acute Myeloid Leukemia (AML)";"MLL-AF9 knockdown";"0";
"37";"Acute Myeloid Leukemia (AML)";"FLT3 wild type";"0";
"38";"Acute Myeloid Leukemia (AML)";"knockdown LncRNA MALAT1";"0";
"39";"Acute Myeloid Leukemia (AML)";"MLL rearrangement t(9;11)";"0";
"40";"Acute Myeloid Leukemia (AML)";"MLL rearrangement ";"0";
"41";"Acute Myeloid Leukemia (AML)";"Acute Megakaryoblastic Leukemia with Down syndrome (DS-AMKL)";"0";
"42";"Acute Myeloid Leukemia (AML)";"non-DS-AMKL";"0";
"43";"Acute Myeloid Leukemia (AML)";"Silencing LncRNA RPPH1 ";"0";
"44";"Acute Myeloid Leukemia (AML)";"silencing LncRNA TUG1";"0";
"45";"Acute Myeloid Leukemia (AML)";"Silencing AML1/ETO ";"0";
"46";"Acute Myeloid Leukemia (AML)";"AML1/ETO positive";"0";
"47";"Acute Myeloid Leukemia (AML)";"MLL-AF4 (KMT2A-AFF1)";"0";
"48";"Acute Myeloid Leukemia (AML)";"High EVI1";"0";
"49";"Acute Myeloid Leukemia (AML)";"homozygous for FLT3-ITD mutation";"0";
"50";"Acute Myeloid Leukemia (AML)";"Silencing circPAN3";"0";
"51";"Acute Myeloid Leukemia (AML)";"Silencing LncRNA MIAT";"0";
"52";"Acute Myeloid Leukemia (AML)";"overexpression of LncRNA HOTAIR";"0";
"53";"Acute Myeloid Leukemia (AML)";"Silencing LINC00152";"0";
"54";"Acute Myeloid Leukemia (AML)";"AML-ETO positive";"0";
"55";"Acute Myeloid Leukemia (AML)";"LncRNA NEAT1 overexpression";"0";
"56";"Acute Myeloid Leukemia (AML)";"LncRNA HOTTIP expressed cells";"0";
"57";"Acute Myeloid Leukemia (AML)";"AML/ETO postive";"0";
"58";"Acute Myeloid Leukemia (AML)";"t(8;21)";"0";
"59";"Acute Myeloid Leukemia (AML)";"silencing LncRNA ANRIL";"0";
"60";"Adrenocortical Carcinoma (ACC)";;"0";
"61";"Adrenocortical Tumor (ACT)";;"0";
"62";"Brain Tumor";"Medulloblastoma";"0";
"63";"Brain Tumor";"Medulloblastoma with Silencing LncRNA ANRIL";"0";
"64";"Brain Tumor";"Medulloblastoma with Migration/Invasion";"0";
"65";"Brain Tumor";"PNET with Migration/Invasion";"0";
"66";"Brain Tumor";"PNET";"0";
"67";"Brain Tumor";"Medulloblastoma with CDK6 positive";"0";
"68";"Brain Tumor";"Medulloblastoma with MMP-9 overexpression";"0";
"69";"Brain Tumor";"Medulloblastoma with P53 mutated ";"0";
"70";"Brain Tumor";"Medulloblastoma with SPARC expression";"0";
"71";"Brain Tumor";"Medullolbastoma";"0";
"72";"Brain Tumor";"Medulloblastom";"0";
"73";"Brain Tumor";"Glioma (Pilocytic Astrocytoma)";"0";
"74";"Brain Tumor";"Glioma (Astrocytoma)";"0";
"75";"Brain Tumor";"Glioma (Anaplastic Astrocytoma)";"0";
"76";"Brain Tumor";"Glioma (GBM)";"0";
"77";"Brain Tumor";"Glioma";"0";
"78";"Brain Tumor";"Glioma (HGG)";"0";
"79";"Brain Tumor";"Medulloblastoma with STAT3 phosphorylation";"0";
"80";"Brain Tumor";"ATRT";"0";
"81";"Brain Tumor";"Glioma(Pilocytic astrocytoma)";"0";
"82";"Brain Tumor";"-";"0";
"83";"Chronic Myelogenous leukemia (CML)";"-";"0";
"84";"Ewing Sarcoma (ES)";"-";"0";
"85";"Hepatoblastoma";"-";"0";
"86";"Hepatoblastoma";"Upregulated lncRNA TUG-1";"0";
"87";"Hepatoblastoma";"silencing LncRNA NEAT1";"0";
"88";"Hepatoblastoma";"silencing LncRNA H19";"0";
"89";"Hepatoblastoma";"HBV (+)";"0";
"90";"Hepatoblastoma";"Silencing LncRNA LUCAT1";"0";
"91";"Hepatoblastoma";"Silencing LncRNA OIP5-AS1";"0";
"92";"Hepatoblastoma";"Sliencing circHMGCS1";"0";
"93";"Hepatoblastoma";"circHMGCS1 expressing cells";"0";
"94";"Hepatoblastoma";"Doxorubicin treated cell (chronic dose)";"0";
"95";"Hepatoblastoma";"CD90+ (surface marker of liver cancer stem cells [LCSCs])";"0";
"96";"Hepatoblastoma";"Endoplasmic Reticulum (ER) stress-induced apoptosis resistance (Tunicamycin-treated)";"0";
"97";"Hepatoblastoma";"VEGF-overexpressing cells";"0";
"98";"Hepatoblastoma";"Normoxia";"0";
"99";"Hepatoblastoma";"hypoxia-induced chemoresistance";"0";
"100";"Hepatoblastoma";"Hypoxia";"0";
"101";"Hepatoblastoma";"HBV +ve";"0";
"102";"Hepatoblastoma";"Metastasis/Vasculogenic Mimicry (VM) formation";"0";
"103";"Hepatoblastoma";"Migration/Metastasis and Invasion";"0";
"104";"Hepatoblastoma";"Invasion";"0";
"105";"Hepatoblastoma";"Migration /Metastasis and Invasion";"0";
"106";"Hepatoblastoma";"Metastasis/Invasion";"0";
"107";"Hepatoblastoma";"Angiogenesis ";"0";
"108";"Hepatoblastoma";"Migration/Angiogenesis";"0";
"109";"Hepatoblastoma";"Migration and Invasion";"0";
"110";"Hepatoblastoma";"Migration and Invasion in HBV +ve cells";"0";
"111";"Hepatoblastoma";"Migration/Metastasis ";"0";
"112";"Hepatoblastoma";"Adriamycin resistant ";"0";
"113";"Hepatoblastoma";"5-FU resistance";"0";
"114";"Hepatoblastoma";"Endoplasmic Reticulum (ER) stress-induced apoptosis resistance";"0";
"115";"Juvenile myelomonocytic leukemia (JMML)";;"0";
"116";"Langerhans cell histiocytosis (LCH)";"-";"0";
"117";"Neueoblastoma (NB)";"-";"0";
"118";"Neueoblastoma (NB)";"MYCN amplified (MNA)";"0";
"119";"Neueoblastoma (NB)";"Non- MYCN amplified (Non-MNA)";"0";
"120";"Neueoblastoma (NB)";"1p32 deletion";"0";
"121";"Neueoblastoma (NB)";"1p36 Deletion";"0";
"122";"Neueoblastoma (NB)";"Low MYCN level";"0";
"123";"Neueoblastoma (NB)";"MYCN amplified";"0";
"124";"Neueoblastoma (NB)";"Invasion";"0";
"125";"Neueoblastoma (NB)";"Non-amplified MYCN ";"0";
"126";"Neueoblastoma (NB)";"P53 wild type";"0";
"127";"Neueoblastoma (NB)";"MYCN amplification (MNA)";"0";
"128";"Neueoblastoma (NB)";"MYCN amplification";"0";
"129";"Neueoblastoma (NB)";"MYCN amplification ";"0";
"130";"Neueoblastoma (NB)";"MYCN-amplifies";"0";
"131";"Neueoblastoma (NB)";"MYCN-amplified (MNA)";"0";
"132";"Neueoblastoma (NB)";"Migration & Invasion ";"0";
"133";"Neueoblastoma (NB)";"MYCN-amplified";"0";
"134";"Neueoblastoma (NB)";"Silencing hTERT";"0";
"135";"Neueoblastoma (NB)";"Migration/Metastasis and Invasion in Non-Amplified MYCN";"0";
"136";"Neueoblastoma (NB)";"Migration/Metastasis and Invasion in MYCN amplified cells ";"0";
"137";"Neueoblastoma (NB)";"Cisplatin resistance ";"0";
"138";"Neueoblastoma (NB)";"MYCN amplification (MYNA)";"0";
"139";"Neueoblastoma (NB)";"BCO1 overexpression";"0";
"140";"Neueoblastoma (NB)";"Migration & Invasion in MYCN amplified cells";"0";
"141";"Neueoblastoma (NB)";"Migration & Invasion in Non-amplified MYCN cells";"0";
"142";"Neueoblastoma (NB)";"Migration";"0";
"143";"Neueoblastoma (NB)";"Migration ";"0";
"144";"Neueoblastoma (NB)";"Metastasis and Angiogenesis";"0";
"145";"Neueoblastoma (NB)";"Drug Resistance";"0";
"146";"Neueoblastoma (NB)";"p53-wild type";"0";
"147";"Neueoblastoma (NB)";"Etoposide Resistance";"0";
"148";"Neueoblastoma (NB)";"silencing LncRNA SNHG7 ";"0";
"149";"Neueoblastoma (NB)";"silencing LncRNA RMRP";"0";
"150";"Neueoblastoma (NB)";"Silencing CASC11 ";"0";
"151";"Neueoblastoma (NB)";"silencing LncRNA SNHG1";"0";
"152";"Neueoblastoma (NB)";"SLC 34A2 overexpression";"0";
"153";"Neueoblastoma (NB)";"p53-mutant";"0";
"154";"Neueoblastoma (NB)";"SK-N-AS";"0";
"155";"Neueoblastoma (NB)";"After intensive treatment and tumor recurrence";"0";
"156";"Neueoblastoma (NB)";"Tumor recurrence";"0";
"157";"Neueoblastoma (NB)";"upregulated after intensive treatment and tumor recurrence";"0";
"158";"Neueoblastoma (NB)";"highest expression of LMO1/ NMYC expression";"0";
"159";"Neueoblastoma (NB)";"highest expression of LMO1/NMYC expression";"0";
"160";"Neueoblastoma (NB)";"MYCN Amplification(MNA)";"0";
"161";"Neueoblastoma (NB)";"Silencing MYCN";"0";
"162";"Neueoblastoma (NB)";"MYCN Overexpression ";"0";
"163";"Neueoblastoma (NB)";"MYCN overexpression";"0";
"164";"Neueoblastoma (NB)";"MYCN Amplification (MNA) ";"0";
"165";"Neueoblastoma (NB)";"Non-amplified MYCN (Non-MNA)";"0";
"166";"Neueoblastoma (NB)";"ATRA-induced differentiation";"0";
"167";"Neueoblastoma (NB)";"MYCN Single Copy ";"0";
"168";"Neueoblastoma (NB)";"ALK expressing cell";"0";
"169";"Neueoblastoma (NB)";"ALK-ve";"0";
"170";"Neueoblastoma (NB)";"Normal MYCN";"0";
"171";"Neueoblastoma (NB)";"Normal NMYC";"0";
"172";"Neueoblastoma (NB)";"MYCN not amplified";"0";
"173";"Neueoblastoma (NB)";"MYCN Amplification MNA)";"0";
"174";"Neueoblastoma (NB)";"Non-amplified MYCN (non-MNA)";"0";
"175";"Neueoblastoma (NB)";" si-HDAC8 (silencing) Dox sensitivity";"0";
"176";"Neueoblastoma (NB)";"Oxygen and Glucose-deprived reoxygenation (OGD/R)";"0";
"177";"Neueoblastoma (NB)";"Non-MYCN amplified (Non-MNA)";"0";
"178";"Neueoblastoma (NB)";"MYCN non amplified";"0";
"179";"Neueoblastoma (NB)";"P53-dependent miR induction";"0";
"180";"Neueoblastoma (NB)";"p53 Independent";"0";
"181";"Neueoblastoma (NB)";"MYCN Single copy";"0";
"182";"Neueoblastoma (NB)";"Oxidative stress";"0";
"183";"Neueoblastoma (NB)";;"0";
"184";"Non-Hodgkin lymphoma (NHL)";"Burkitt�s lymphoma ";"0";
"185";"Non-Hodgkin lymphoma (NHL)";"Burkitt lymphoma ";"0";
"186";"Non-Hodgkin lymphoma (NHL)";"EBV-positive Burkitt's lymphoma (BL)";"0";
"187";"Non-Hodgkin lymphoma (NHL)";"Burkitt lymphoma (BL)";"0";
"188";"Non-Hodgkin lymphoma (NHL)";"Natural killer cell lymphoblastic leukemia/lymphoma";"0";
"189";"Non-Hodgkin lymphoma (NHL)";"EBV-positive Burkitt's lymphoma";"0";
"190";"Non-Hodgkin lymphoma (NHL)";"EBV positive Burkitt's lymphoma";"0";
"191";"Non-Hodgkin lymphoma (NHL)";"T-cell lymphoblastic leukemia with high Circ-LAMP1";"0";
"192";"Non-Hodgkin lymphoma (NHL)";"T-cell lymphoblastic lymphoma with high Circ-LAMP1";"0";
"193";"Non-Hodgkin lymphoma (NHL)";"(ALK+) anaplastic large cell lymphoma (ALCL)";"0";
"194";"Non-Hodgkin lymphoma (NHL)";"ALK-positive anaplastic large cell lymphoma (ALCL)";"0";
"195";"Non-Hodgkin lymphoma (NHL)";"EBV-positive Burkitt lymphoma (BL)";"0";
"196";"Non-Hodgkin lymphoma (NHL)";"Diffuse large B-cell lymphoma (DLBCL)";"0";
"197";"Non-Hodgkin lymphoma (NHL)";" T-cell lymphoblastic leukaemia(T-LL)";"0";
"198";"Non-Hodgkin lymphoma (NHL)";"ALK-positive anaplastic large cell lymphoma ( (ALCL)";"0";
"199";"Non-Hodgkin lymphoma (NHL)";"EBV-positive Burkitt lymphoma (BL)";"0";
"200";"Non-Hodgkin lymphoma (NHL)";"Burkitt Lymphoma (BL)";"0";
"201";"Non-Hodgkin lymphoma (NHL)";"Burkitt's Lymphoma (BL)";"0";
"202";"Non-Hodgkin lymphoma (NHL)";"EBV-ve,NK/T-cell lymphoma";"0";
"203";"Non-Hodgkin lymphoma (NHL)";"Burkitt's lymphoma";"0";
"204";"Non-Hodgkin lymphoma (NHL)";"T-cell lymphoblastic leukemia";"0";
"205";"Non-Hodgkin lymphoma (NHL)";"T-cell lymphoblastic lymphoma";"0";
"206";"Non-Hodgkin lymphoma (NHL)";"Epstein-Barr virus-positive Burkitt Lymphoma (BL)";"0";
"207";"Non-Hodgkin lymphoma (NHL)";"NPM-ALK-positive anaplastic large cell lymphoma (ALCL)";"0";
"208";"Non-Hodgkin lymphoma (NHL)";"Burkitt lymphoma";"0";
"209";"Non-Hodgkin lymphoma (NHL)";"ALK+ ALCL";"0";
"210";"Non-Hodgkin lymphoma (NHL)";"-";"0";
"211";"Osteosarcoma (OS)";"OS with silenced circ-NT5C2";"0";
"212";"Osteosarcoma (OS)";"-";"0";
"213";"Osteosarcoma (OS)";"OS with ADPGK-AS1 knockdowned";"0";
"214";"Osteosarcoma (OS)";"OS with overexpression of UCA1";"0";
"215";"Osteosarcoma (OS)";"OS with high SNHG16 expression";"0";
<br />
<b>Fatal error</b>: Uncaught TypeError: Return value of PhpMyAdmin\Encoding::convertString() must be of the type string, bool returned in C:\xampp\phpMyAdmin\libraries\classes\Encoding.php:200
Stack trace:
#0 C:\xampp\phpMyAdmin\libraries\classes\Export.php(154): PhpMyAdmin\Encoding::convertString('utf-8', 'windows-1252', '"216";"Osteosar...')
#1 C:\xampp\phpMyAdmin\libraries\classes\Plugins\Export\ExportCsv.php(339): PhpMyAdmin\Export->outputHandler('"216";"Osteosar...')
#2 C:\xampp\phpMyAdmin\libraries\classes\Export.php(998): PhpMyAdmin\Plugins\Export\ExportCsv->exportData('m3c', 'traits', '\r\n', 'tbl_export.php?...', 'SELECT `ID_Trai...', Array)
#3 C:\xampp\phpMyAdmin\export.php(578): PhpMyAdmin\Export->exportTable('m3c', 'traits', 'data', Object(PhpMyAdmin\Plugins\Export\ExportExcel), '\r\n', 'tbl_export.php?...', 'table', false, false, false, false, '1', '0', '0', '', Array)
#4 {main}
thrown in <b>C:\xampp\phpMyAdmin\libraries\classes\Encoding.php</b> on line <b>200</b><br />